11/14/2024 4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 1:35 PM | DAFNA Capital Management LLC (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024 3:26 PM | Regulus Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024 3:02 PM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 1:02 PM | BlackRock, Inc. (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G | |
08/08/2024 3:24 PM | Regulus Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
07/29/2024 3:18 PM | Collier Kathryn J (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 6:23 AM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 3:20 PM | Aker Christopher Ray (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:21 PM | CALSADA CRISPINA (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:21 PM | Hagan Joseph P (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 4:16 PM | Collier Kathryn J (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:33 PM | Huang Alice Shih-hou (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:54 PM | Regulus Therapeutics (Filer)
| Form 424B5 | |
04/21/2024 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
04/19/2024 3:13 PM | Regulus Therapeutics (Filer)
| Form ARS | |
04/10/2024 9:06 AM | FMR LLC (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
04/09/2024 3:55 PM | Regulus Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/25/2024 3:18 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G | |
03/22/2024 3:03 PM | Deep Track Capital, LP (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G | |
03/21/2024 3:28 PM | Regulus Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/21/2024 3:18 PM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 3:30 PM | Regulus Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
03/18/2024 8:13 PM | Growth Equity Opportunities V, LLC (Filed by) Regulus Therapeutics (Subject)
| Form SC 13D/A | |
03/15/2024 3:19 PM | PAPADOPOULOS STELIOS (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:57 PM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024 10:06 AM | Regulus Therapeutics (Subject) VICTORY CAPITAL MANAGEMENT INC (Filed by)
| Form SC 13G/A | |
01/18/2024 7:22 PM | Hagan Joseph P (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 7:23 PM | Aker Christopher Ray (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 7:24 PM | CALSADA CRISPINA (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 9:25 AM | FEDERATED HERMES, INC. (Filed by) FEDERATED HERMES, INC. (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
01/17/2024 4:16 PM | Hagan Joseph P (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:18 PM | Klassen Preston (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:04 PM | Aker Christopher Ray (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:08 PM | CALSADA CRISPINA (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:11 PM | Regulus Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/09/2024 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
12/27/2023 3:16 PM | Regulus Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |